WESLEY DRIVER: Open Payments
NPI 1316590482 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 41 payments from 12 companies in 2025. Trend: 2023 $742 · 2024 $1,069 · 2025 $895
Food & beverage: $895
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $311 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| GENZYME CORPORATION | 5 | $94 |
| Verona Pharma, Inc. | 4 | $83 |
| Inspire Medical Systems, Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Viatris Specialty LLC | 2 | $44 |
| Grifols USA, LLC | 1 | $32 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: TRELEGY ELLIPTA, DUPIXENT, NUCALA, Ohtuvayre, INSPIRE, YUPELRI, AIRSUPRA, Prolastin-C Liquid.
Industry payments across AL — which companies pay providers there.
